Life sciences and the IPO journey

Oct 18, 2021
Medtech Technical accounting Biopharma

Life sciences organizations are going public in 2021 with biotech companies leading the pack as the dominant sector within the industry for new market entrants. By midyear, biotech has made up roughly 70% of all life sciences initial public offerings and capital raised, according to Bloomberg analysis.

Chris Martin, technical accounting consulting lead for RSM’s life sciences practice, discusses what’s driving this IPO trend in this brief video with Informa Connect. In addition, Chris shares what life sciences companies should do to prepare for an IPO now. According to him, people, processes, systems and controls are all part of the successful IPO equation, but there’s more to address, too. Watch and learn.

Stay up to date on what matters most to your business.

Let us know your personal preferences for topics, industries and services to start receiving RSM updates in your inbox. Get the most from insights, events and offers from our team of first-choice advisors.